{
    "藥化":{
    "第一章-觀念題": [
      {
        "question": "下列何者不是基因突變（mutation）常見的現象？",
        "options": ["A. 取代（substitution）", "B. 加成（addition）", "C. 刪除（deletion）", "D. 封頂（capping）"],
        "answer": "D. 封頂（capping）",
        "explanation": "基因突變的常見現象包括取代、加成和刪除，封頂並不是常見的基因突變類型。"
      },
      {
        "question": "下列何者最適合作為 phenyl 的等效異構基團？",
        "options": ["A. benzyl", "B. hexyl", "C. cyclohexyl", "D. pyridinyl"],
        "answer": "D. pyridinyl",
        "explanation": "Pyridinyl 結構在藥物設計中常作為 phenyl 基團的等效異構基團。"
      },
      {
        "question": "下圖化合物在健康人的空腹胃中，最主要的電荷態為：",
        "options": ["A.+1", "B.0", "C.-1", "D.-2"],
        "answer": "A.+1",
        "explanation": "化合物的電荷態受 pH 影響，通常在酸性環境中，會呈現正電荷。"
      }
    ],
    "第二章-抗生素": [
      {
        "question": "下列何者屬於 monobactam 抗生素？",
        "options": ["A. aztreonam", "B. ertapenem", "C. meropenem", "D. sulbactam"],
        "answer": "A. aztreonam",
        "explanation": "Aztreonam 是單環 beta-lactam 抗生素，屬於 monobactam 類。"
      },
      {
        "question": "下列何種四環素不含 C-6-OH，所以不進行脫水反應？",
        "options": ["A. chlortetracycline", "B. demeclocycline", "C. minocycline", "D. oxytetracycline"],
        "answer": "C. minocycline",
        "explanation": "Minocycline 是四環素類抗生素，結構中缺少 C-6-OH 基團，因此不進行脫水反應。"
      },
      {
        "question": "下列 chloramphenicol（結構如下圖）異構物組態，何者具有顯著抗菌活性？",
        "options": ["A. 1R，2R", "B. 1R，2S", "C. 1S，2S", "D. 1S，2R"],
        "answer": "A. 1R，2R",
        "explanation": "Chloramphenicol 的抗菌活性與其異構物組態密切相關，1R，2R 異構物具有最強的抗菌活性。"
      }
    ]
    }
  }
  